HDAC2 and asthma: HDAC2 activity and expression are reduced in severe asthma, which may account for the increased inflammation and resistance to corticosteroid action [47,48].These findings suggest that these three miRNAs, particularly miR-339-3p, play an important role in immune dysregulation, which results in poor response to ICS treatment.